Analysis

All eyes are on Victory Capital as it approaches the release of its fourth-quarter 2025 financial figures. The key question...

Investor focus has intensified on Insmed Incorporated this week, driven by promising clinical data presentations and a notably bullish assessment...

As major indices like the S&P 500 reach for new highs, investors are increasingly scrutinizing specialized financial data providers. In...

Biotechnology firm Ocugen has bolstered its financial position through a recent capital raise, providing crucial resources as it approaches significant...

Despite facing significant headwinds from a volatile cryptocurrency market, Coinbase continues to execute on its long-term expansion strategy. The company's...

Biopharmaceutical company Viking Therapeutics has moved its lead obesity treatment candidate into the final stage of clinical development, following the...

As the market anticipates its upcoming financial release, Iqvia has announced a significant expansion of its strategic footprint through a...

The financial technology giant Fiserv is confronting fresh legal challenges from a Florida-based credit union, alleging security failures in its...

Protalix Biotherapeutics is entering a period defined by significant upcoming regulatory and clinical milestones. Following a strategic update in early...

As the quantum computing sector enters 2026, a stark divergence is unfolding. The two companies once considered peers in the...